RESMED INC (RMD)

↓ Download CSV

CIK 0000943819 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

In fiscal 2026, RESMED INC reported revenue of $5.65B, up 9.9% from the prior year. The company was profitable, with a net margin of 26.9% and a gross margin of 61.1%. It held $8.97B in total assets against $2.38B in total liabilities.

Key ratios (FY2026)

61.1%
Gross margin
33.4%
Operating margin
26.9%
Net margin
23.1%
Return on equity
+9.9%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020201920182017
Revenue$5.65B$5.15B$4.69B$4.22B$3.58B$3.20B$2.96B$2.61B$2.34B$2.07B
Cost of Revenue$2.20B$2.09B$2.03B$1.87B$1.55B$1.36B$1.24B$1.11B$1.01B$864.99M
Gross Profit$3.45B$3.05B$2.66B$2.36B$2.02B$1.84B$1.72B$1.49B$1.33B$1.20B
Operating Income$1.89B$1.69B$1.32B$1.13B$1.00B$903.68M$809.66M$579.26M$541.83M$425.80M
Net Income$1.52B$1.40B$1.02B$897.56M$779.44M$474.50M$621.67M$404.59M$315.59M$342.28M
EPS (Diluted)$10.43$9.51$6.92$6.09$5.30$3.24$4.27$2.80$2.19$2.40
Total Assets$8.97B$8.17B$6.87B$6.75B$5.10B$4.73B$4.59B$4.11B$3.06B$3.47B
Total Liabilities$2.38B$2.21B$2.01B$2.62B$1.74B$1.84B$2.09B$2.04B$1.00B$1.51B
Shareholders' Equity$6.59B$5.97B$4.86B$4.13B$3.36B$2.89B$2.50B$2.07B$2.06B$1.96B
Cash & Equivalents$1.47B$1.21B$238.36M$227.89M$273.71M$295.28M$463.16M$147.13M$188.70M$821.93M
Operating Cash Flow$1.81B$1.75B$1.40B$693.30M$351.15M$736.72M$802.25M$459.05M$505.03M$414.05M
Capital Expenditures$156.28M$89.86M$99.46M$119.67M$134.84M$102.71M$95.33M$68.71M$62.58M$62.22M
Shares Outstanding146.05M147.34M147.55M147.46M147.04M146.45M145.65M144.48M143.99M142.45M
Dividends Per Share$2.40$2.12$1.92$1.76$1.68$1.56$1.56$1.48$1.40$1.32